Kreon (Pancreas Powder)

Pancreatin provides a mixture of lipase, amylase, and protease enzymes that mimic natural pancreatic secretions. After the enteric coating dissolves in the small intestine, these enzymes break down dietary fats, starches, and proteins, improving nutrient absorption and reducing malabsorption symptoms.

The appropriate dose of Kreon is individualized by the prescribing healthcare professional based on the patient’s age, weight, severity of enzyme deficiency, and dietary fat content. Patients should follow the prescriber’s instructions and adjust dosing only under medical guidance.

The safety of Kreon in pregnancy or lactation has not been definitively established. Healthcare providers weigh potential benefits against unknown risks before prescribing it to pregnant or nursing women. Patients should discuss any concerns with their physician.

To request Kreon, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any required temperature control), and import documentation.

Kreon contains porcine‑derived pancreatin similar to other branded enzyme preparations such as Creon or Pancrelipase. Differences may lie in enzyme potency per capsule, coating technology, and regulatory status. Clinicians choose a product based on individual patient response, dosing convenience, and local availability.

Kreon should be stored at room temperature, below 25 °C, in its original blister pack to protect the enteric coating from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Kreon is taken orally, swallowed whole with a full glass of water during or immediately after meals and snacks. The enteric coating ensures the enzymes are released in the small intestine where they can act on ingested food.

Serious adverse events include severe allergic reactions (anaphylaxis), pancreatitis, intestinal obstruction, and persistent vomiting leading to dehydration. Patients should seek immediate medical attention if they experience intense abdominal pain, swelling, difficulty breathing, or any signs of an allergic response.

Kreon is contraindicated in individuals with a known hypersensitivity to porcine proteins or any component of the formulation. It should also be used with caution in patients with severe gastrointestinal disorders that could impair capsule dissolution or increase the risk of obstruction.